Skip to content
DD STOCK
  • Home
  • technology
  • Unnecessary
  • Health Care
  • Necessary
  • Financials
  • Energy
  • Industrials
  • Basic Materials
  • Telecommunications
  • Utilities
DD STOCK
  • Home
  • technology
  • Unnecessary
  • Health Care
  • Necessary
  • Financials
  • Energy
  • Industrials
  • Basic Materials
  • Telecommunications
  • Utilities

Home » Pfizer » Pfizer: Current Financial Guidance Doesn’t Anticipate Any Share Repurchases in 2023

Pfizer: Current Financial Guidance Doesn’t Anticipate Any Share Repurchases in 2023

By legume / November 1, 2023 / Pfizer

Pfizer: Current Financial Guidance Doesn’t Anticipate Any Share Repurchases in 2023

Previous

Pfizer Q3 Adjusted EPS $(0.17) Beats $(0.32) Estimate, Sales $13.23B Beat $12.72B Estimate

Next

Pfizer Q3 Adj. Per-share Loss 17 Cents Vs. EPS $1.78 a Year Ago, Misses the FactSet

Recent Posts

  • Snowflake (SNOW) Q1 2026 Earnings Call Transcript
  • Walmart, Inc. (WMT) Q1 2026 Earnings Call transcript
  • Applied Materials (AMAT) Q2 2025 Earnings Call Transcript
  • Cisco Systems, Inc. (CSCO) Q3 2025 Earnings Call Transcript
  • Can UnitedHealth’s New Boss Succeed Where Other ‘Boomerang’ CEOs Failed?

Recent Comments

No comments to show.

Tag Cloud

Adobe Alphabet Amazon AMD Apple Bank of America Barclays Boeing Broadcom Citigroup Costco CrowdStrike Deutsche Bank Disney Eli Lilly Estee Lauder FedEx Goldman Sachs Intel Jefferies JPMorgan Lululemon McDonald Meta Platforms Micron Technology Microsoft Mizuho Morgan Stanley Netflix Nike Nvidia Oppenheimer Piper Sandler Raymond James Royal Bank of Canada Salesforce Snowflake Starbucks Target Tesla Uber UBS Walmart Wedbush Wells Fargo

友情链接:豆豆小说 股票研究报告 股票行情分析

Copyright © 2025 DD STOCK

Scroll to Top